U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06982092) titled 'Using Diaphragm Ultrasonography, Sugammadex Recovers Diaphragmatic Function More Effectively Than Neostigmine.' on April 04.
Brief Summary: The aim of our study is to assess differences in the recovery of muscle function, using diaphragm ultrasonography, after reversal of a rocuronium-induced block, using neostigmine versus sugammadex
Study Start Date: Aug. 26, 2024
Study Type: INTERVENTIONAL
Condition:
Perioperative Diaphragmatic Function
Intervention:
DRUG: sugammadex
: patients will receive the reversal drug according to the group to which they had been randomised. in the Sugammadex Group will receive 2 mg/kg sugammadex.
D...